Clinical Trial Update: Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

View source ↗

Summary

An update reporting on the analysis of effectiveness and safety of teclistamab in patients with relapsed and refractory multiple myeloma in a trial that is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Intergroupe Francophone du Myelome | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING